The inhibition of ABCB1/MDR1 or ABCG2/BCRP enables doxorubicin to eliminate liver cancer stem cells
Abstract Two ATP-binding cassette transporters, ABCB1/MDR1 and ABCG2/BCRP, are considered the most critical determinants for chemoresistance in hepatocellular carcinoma. However, their roles in the chemoresistance in liver cancer stem cells remain elusive. Here we explored the role of inhibition of...
Guardado en:
Autores principales: | Wang Yin, Dongxi Xiang, Tao Wang, Yumei Zhang, Cuong V. Pham, Shufeng Zhou, Guoqin Jiang, Yingchun Hou, Yimin Zhu, Yinglu Han, Liang Qiao, Phuong H.-L. Tran, Wei Duan |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/67c194d8536544da957644e48e94460b |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
P-Glycoprotein (ABCB1/MDR1) and BCRP (ABCG2) Limit Brain Accumulation and Cytochrome P450-3A (CYP3A) Restricts Oral Exposure of the RET Inhibitor Selpercatinib (RETEVMO)
por: Yaogeng Wang, et al.
Publicado: (2021) -
The MDR1/ABCB1 gene rs1045642 polymorphism in colorectal cancer
por: Beata Mrozikiewicz-Rakowska, et al.
Publicado: (2019) -
Modulating drug resistance by targeting BCRP/ABCG2 using retrovirus-mediated RNA interference.
por: Ni Xie, et al.
Publicado: (2014) -
A comprehensive investigation on common polymorphisms in the MDR1/ABCB1 transporter gene and susceptibility to colorectal cancer.
por: Daniele Campa, et al.
Publicado: (2012) -
Metabolomic and transcriptomic analysis reveals endogenous substrates and metabolic adaptation in rats lacking Abcg2 and Abcb1a transporters.
por: Samit Ganguly, et al.
Publicado: (2021)